PODD241220P260000
- 4.05
- 0.000.00%
Insulet Newsroom
Tuesday S&P 500 Pulls Back From Highs, Nasdaq Climbs | Live Stock
United States Diabetes Device Market Forecast Report and Company Analysis 2024-2032 Featuring BD, Roche, Medtronic, Insulet, Abbott, Dexcom, Tandem Diabetes Care, Ypsomed Novo Nordisk, Eli Lilly - ResearchAndMarkets.com
S&P 500 and Nasdaq Hit Closing and Trading Highs Monday | Wall Street Today
December Starts With a Mixed Market | Live Stock
Here's Why Insulet (PODD) Is a Strong Growth Stock
Does Insulet (NASDAQ:PODD) Deserve A Spot On Your Watchlist?
Leerink Partners Keeps Their Buy Rating on Insulet (PODD)
Wednesday Ends With Index Decline | Wall Street Today
Peering Into Insulet's Recent Short Interest
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Are Wall Street Analysts Predicting Insulet Stock Will Climb or Sink?
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
If You Invested $1000 in Insulet a Decade Ago, This Is How Much It'd Be Worth Now
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
S&P 500, Dow Hit Records Right After Open | Live Stock
Express News | Insulet Corp : Leerink Partners Raises Target Price to $290 From $278
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Market Climbs, Bitcoin Close to $100k | Live Stock
PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in US